4.4 Article

Nitroimidazole derivatives potentiated against tumor hypoxia: Design, synthesis, antitumor activity, molecular docking study, and QSAR study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Physical

Nitroimidazole-sulfonamides as carbonic anhydrase IX and XII inhibitors targeting tumor hypoxia: Design, synthesis, molecular docking and molecular dynamics simulation

Aya M. Almatary et al.

Summary: In this study, dual drugs were developed that can inhibit carbonic anhydrase enzyme (CA) by containing sulfonamide group, and increase the sensitivity of hypoxic tumors to radio and chemotherapies by incorporating 5-nitroimidazole scaffold. The synthesized compounds demonstrated high cytotoxic activity against multiple cancer cell lines and enhanced the lethal effect of gamma-irradiation. Molecular docking and molecular dynamics simulation were performed to understand the inhibitory effect and stability of interaction.

JOURNAL OF MOLECULAR STRUCTURE (2022)

Article Medicine, Research & Experimental

Licochalcone A inhibits hypoxia-inducible factor-1 α accumulation by suppressing mitochondrial respiration in hypoxic cancer cells

Min Kyung Park et al.

Summary: Licochalcone A, a component of Glycyrrhiza uralensis, demonstrates potential as a therapeutic agent in hypoxic cancer cells by inhibiting HIF-1 alpha accumulation and mitochondrial respiration, leading to increased oxygen content and suppression of cancer cell viability.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Biotechnology & Applied Microbiology

In silico design and molecular docking study of CDK2 inhibitors with potent cytotoxic activity against HCT116 colorectal cancer cell line

Fabian Adakole Ikwu et al.

JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY (2020)

Article Chemistry, Medicinal

Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides

Muriel Bonnet et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Biochemical Research Methods

Integrated omics profiling identifies hypoxia-regulated genes in HCT116 colon cancer cells

Jeng-Ting Chen et al.

JOURNAL OF PROTEOMICS (2018)

Review Biochemistry & Molecular Biology

Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole

Teresa Glomb et al.

MOLECULES (2018)

Review Oncology

Improving radiotherapy in cancer treatment: Promises and challenges

Helen H. W. Chen et al.

ONCOTARGET (2017)

Review Oncology

Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review

Ramandeep Kaur et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Synthesis and in vitro antiproliferative activity of new 1,3,4-oxadiazole derivatives possessing sulfonamide moiety

Mahmoud M. Gamal El-Din et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

Design, synthesis and SAR exploration of tri-substituted 1,2,4-triazoles as inhibitors of the annexin A2-S100A10 protein interaction

Tummala R. K. Reddy et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2014)

Article Chemistry, Medicinal

1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells

Sergio Valente et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Chemistry, Medicinal

Synthesis and anti-inflammatory evaluation of some condensed [4-(3,4-dimethylphenyl)-1(2H)-oxo-phthalazin-2-yl]acetic acid hydrazide

Mosaad S. M. Abd Alla et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)

Editorial Material Pharmacology & Pharmacy

Zibotentan for the treatment of castrate-resistant prostate cancer

Dale R. Shepard et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)

Review Oncology

Exploiting tumour hypoxia in cancer treatment

JM Brown et al.

NATURE REVIEWS CANCER (2004)